Kantify’s Post

View organization page for Kantify, graphic

3,220 followers

Day 2 of REXPO24, Conference on drug repurposing, is underway. Today, Kantify's CTO Nik Subramanian presented some of our novel findings on using Artificial Intelligence to find repurposed drugs which are effective on rare cancers. In his presentation "AI and phenotypic screens lead to the discovery of common treatments for multiple distinct rare diseases with shared commonalities - a use case and what's next", Nik demonstrated how we use Kantify's AI platform to find novel therapeutics targets and drugs. He shared our extremely promising results on some rare cancers with no cures, where in less than 5 months we have successfully predicted and validated novel targets and drugs. Exciting! Harald H.H.W. Schmidt Nik Subramanian REPO4EU Xavier Nissan Maya Jeitany

  • No alternative text description for this image
  • No alternative text description for this image
Ségolène Martin

CEO at Kantify | Accelerating drug discovery in cancer and rare diseases, with Artificial Intelligence

3mo

Exciting is the word! Proud is another :)

LECARPENTIER Elisabeth

Human Resources Coordinator

3mo

I completely agree with you👏🏻👏🏻👏🏻❤️

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics